Pradaxa ®: First NOAC to be assessed in prospective study in patients with blood clots in the veins or venous sinuses of the brain

Pradaxa ®: First NOAC to be assessed in prospective study in patients with blood clots in the veins or venous sinuses of the brain

Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news